Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)
- PMID: 27156763
- DOI: 10.1016/j.beem.2016.02.010
Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)
Abstract
Nephrogenic diabetes insipidus (NDI), which can be inherited or acquired, is characterized by an inability to concentrate urine despite normal or elevated plasma concentrations of the antidiuretic hormone, arginine vasopressin (AVP). Polyuria with hyposthenuria and polydipsia are the cardinal clinical manifestations of the disease. About 90% of patients with congenital NDI are males with X-linked NDI who have mutations in the vasopressin V2 receptor (AVPR2) gene encoding the vasopressin V2 receptor. In less than 10% of the families studied, congenital NDI has an autosomal recessive or autosomal dominant mode of inheritance with mutations in the aquaporin-2 (AQP2) gene. When studied in vitro, most AVPR2 and AQP2 mutations lead to proteins trapped in the endoplasmic reticulum and are unable to reach the plasma membrane. Prior knowledge of AVPR2 or AQP2 mutations in NDI families and perinatal mutation testing is of direct clinical value and can avert the physical and mental retardation associated with repeated episodes of dehydration.
Keywords: AQP2; AVPR2; Autosomal recessive nephrogenic diabetes insipidus; Cyclic AMP; Dehydration; Misfolded proteins; Nephrogenic diabetes insipidus; X-linked nephrogenic diabetes insipidus.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Nephrogenic diabetes insipidus.Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006. Adv Chronic Kidney Dis. 2006. PMID: 16580609 Review.
-
V2R mutations and nephrogenic diabetes insipidus.Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7. Prog Mol Biol Transl Sci. 2009. PMID: 20374732 Review.
-
Physiopathology and diagnosis of nephrogenic diabetes insipidus.Ann Endocrinol (Paris). 2012 Apr;73(2):128-9. doi: 10.1016/j.ando.2012.03.032. Epub 2012 Apr 13. Ann Endocrinol (Paris). 2012. PMID: 22503803 Review.
-
AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.Cells. 2020 Sep 26;9(10):2172. doi: 10.3390/cells9102172. Cells. 2020. PMID: 32993088 Free PMC article. Review.
-
Nephrogenic diabetes insipidus.Annu Rev Physiol. 2001;63:607-30. doi: 10.1146/annurev.physiol.63.1.607. Annu Rev Physiol. 2001. PMID: 11181969 Review.
Cited by
-
Phenotype heterogeneity of congenital adrenal hyperplasia due to genetic mosaicism and concomitant nephrogenic diabetes insipidus in a sibling.BMC Med Genet. 2018 Jul 11;19(1):115. doi: 10.1186/s12881-018-0629-2. BMC Med Genet. 2018. PMID: 29996815 Free PMC article.
-
[Family form of nephrogenic X-linked diabetes indiabetes].Probl Endokrinol (Mosk). 2022 Jul 13;68(5):87-90. doi: 10.14341/probl13098. Probl Endokrinol (Mosk). 2022. PMID: 36337022 Free PMC article. Russian.
-
Exploring the diversity of AVPR2 in Primates and its evolutionary implications.Genet Mol Biol. 2023 Nov 3;46(3):e20230045. doi: 10.1590/1678-4685-GMB-2023-0045. eCollection 2023. Genet Mol Biol. 2023. PMID: 37930141 Free PMC article.
-
A 4-year-old boy presenting with persistent urinary incontinence: Answers.Pediatr Nephrol. 2017 May;32(5):769-771. doi: 10.1007/s00467-016-3442-1. Epub 2016 Jun 27. Pediatr Nephrol. 2017. PMID: 27350624 No abstract available.
-
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).Nat Rev Nephrol. 2025 Feb;21(2):83-96. doi: 10.1038/s41581-024-00897-z. Epub 2024 Oct 22. Nat Rev Nephrol. 2025. PMID: 39438674 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous